Kelly Chibale: Learning to Fail Your Way to Success
Keywords:Africa, Antimalarial drugs
A portrait is given of Professor Kelly Chibale, the driving force behind H3D, the drug discovery and development centre at the University of Cape Town, South Africa. He is dedicated to the development of new drugs to fight infectious diseases of poverty that are prevalent in Africa, including MMV390048, the first anti-malarial drug ever to be validated in a Phase I trial in Africa. In 2018 he was recognized as one of Fortune magazine’s top 50 ‘World’s Greatest Leaders’.
How to Cite
Copyright (c) 2023 Lukas Meier
This work is licensed under a Creative Commons Attribution 4.0 International License.